BE546430A - - Google Patents
Info
- Publication number
- BE546430A BE546430A BE546430DA BE546430A BE 546430 A BE546430 A BE 546430A BE 546430D A BE546430D A BE 546430DA BE 546430 A BE546430 A BE 546430A
- Authority
- BE
- Belgium
- Prior art keywords
- compositions
- alpha
- pharmaceutical compositions
- aqueous
- disulfonate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 description 29
- 239000008194 pharmaceutical composition Substances 0.000 description 18
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 9
- 239000007900 aqueous suspension Substances 0.000 description 9
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 7
- 239000002270 dispersing agent Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 239000000375 suspending agent Substances 0.000 description 5
- CBQDTCDOVVBGMN-UHFFFAOYSA-N 2-methyl-3-octylphenol Chemical compound CCCCCCCCC1=CC=CC(O)=C1C CBQDTCDOVVBGMN-UHFFFAOYSA-N 0.000 description 4
- 206010024229 Leprosy Diseases 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229960002242 chlorocresol Drugs 0.000 description 4
- 239000007859 condensation product Substances 0.000 description 4
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 239000003589 local anesthetic agent Substances 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009837 dry grinding Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 2
- 229960004919 procaine Drugs 0.000 description 2
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 2
- 229940066675 ricinoleate Drugs 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000001238 wet grinding Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- 101100323726 Dictyostelium discoideum arrJ gene Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241001377010 Pila Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- -1 carboxy- Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE546430A true BE546430A (show.php) |
Family
ID=173739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE546430D BE546430A (show.php) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE546430A (show.php) |
-
0
- BE BE546430D patent/BE546430A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0480982B2 (fr) | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable | |
| EP0480981B1 (fr) | Emulsions multiphasiques injectables | |
| EP0804241B1 (fr) | Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables | |
| EP0064967A1 (fr) | Procédé de préparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant | |
| EP0494022B1 (fr) | Nouveaux copolymères à base de N-alkyl acrylamide, leur préparation et leur utilisation comme agents épaississants, notamment dans des compositions de shampooing | |
| FR2811565A1 (fr) | Emulsion eau-dans-huile et ses utilisations notamment dans le domaine cosmetique | |
| FR2628632A1 (fr) | Microemulsions a usage cosmetique ou pharmaceutique | |
| CN118339175A (zh) | 包含糖脂的组合物 | |
| FR2700957A1 (fr) | Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation. | |
| FR2922767A1 (fr) | Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant. | |
| BE546430A (show.php) | ||
| RU2757230C2 (ru) | Композиции загущенных органических жидкостей с полимерными модификаторами реологии | |
| FR2604625A1 (fr) | Procede pour la fabrication de compositions cosmetiques a base d'acide alginique et compositions cosmetiques obtenues | |
| WO2019016492A1 (fr) | Composition comprenant une concentration élevée en lipopeptides ituriniques | |
| EP0827691A1 (fr) | Composition nettoyante et décontaminante en poudre, et procédé d'obtention | |
| CN114177284A (zh) | 一种兽用疫苗的自乳化型佐剂、制备方法及应用 | |
| EP1385475A2 (fr) | Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant | |
| BE546429A (show.php) | ||
| WO2002089762A1 (fr) | Emulsion e/h concentree | |
| KR100386397B1 (ko) | 투명한 프로포폴 주사제 | |
| BE563013A (show.php) | ||
| TW202600172A (zh) | 載體組合物 | |
| FR2825276A1 (fr) | Adujvant d'immunite sous forme solide et vaccin le contenant | |
| FR2793418A1 (fr) | Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee | |
| BE539644A (show.php) |